Our magazine is free!

for living with diabetes

New T2 drug from Sanofi-Aventis proving successful in trials

Sanofi-Aventis said that lixisenatide, an experimental Type 2 diabetes drug, has been very successful in a late stage trial at helping patients reduce their blood sugar levels and lose weight, according to a recent article from Reuters, as reported by Diabetes Newshound.

The study also found that the drug didn’t raise patients’ risk of hypoglycemia compared to a placebo.

The drug works by stimulating the pancreas to release extra insulin when blood sugar levels run too high. If the drug received FDA approval, it would compete against Victoza and Amylin from Novo Nordisk and Byetta from Eli Lilly.

Sign up to our Magazine »

Leave a Comment

Submit Comment »

No Comments Yet!


nl-imageDirect to your inbox, our

free online magazine.

Sign up for the Desang Diabetes Magazine for new products, special offers and news.

*We will never email you more often than once a week (usually once a month). You can easily unsubscribe at any time. It’s finger-pricking good!

Close Don't show again